Skip to main content
. 2015 Nov 1;25(11):1217–1223. doi: 10.1089/thy.2015.0305

FIG. 4.

FIG. 4.

Predicted NPV and PPV of ThyroSeq v2.1 compared to the Afirma gene expression classifier test in AUS/FLUS nodules based on the sensitivity and specificity of ThyroSeq (solid lines) identified in this study and of Afirma (dashed lines) reported by Alexander et al. (14). Color images available online at www.liebertpub.com/thy